3 Researchers Developing Innovative Strategies In Cancer Therapy
To mark World Cancer Day, we've highlighted some innovative strategies for cancer therapy developed in Israel.
February 03, 2022
ImmPACT Bio Raises $111M For Its Next-Generation Cancer Cell Therapy
ImmPACT Bio was formed from a merger with Israeli company Immpact, which was raised in the FutuRX biotech incubator, and US company Kalthera.
January 26, 2022
Cancer Therapy Startup Alpha Tau To Go Public At $1B Valuation
Alpha Tau signed an agreement with Nasdaq-listed SPAC Healthcare Capital Corp to continue delivering on its radiation cancer treatment.
July 15, 2021
Alpha Tau Gets FDA Breakthrough Device Designation For Cancer Therapy
Founded in 2016, Alpha Tau developed a breakthrough cancer treatment called Alpha DaRT (Dіffusіng Alpha-emіtters Radіatіon Therapy).
June 13, 2021
Israeli Startup OncoHost Raises $8M For AI Precision Oncology Platform
Oncohost developed a platform to identify key biological processes and proteins that drive response in patients undergoing cancer treatment.
January 19, 2021
Israeli Cancer Therapy Firm Alpha Tau Medical Raises $26M
The company developed breakthrough radiation cancer therapy and is embarking on a number of new of clinical trials.
June 04, 2020
4 New Developments In Cancer Research, Detection, And Treatment From Israel
To mark World Cancer Day, NoCamels is highlighting some recent findings in research, clinical trials, detection methods, and new therapies - all from so far this year.
February 04, 2019
Breakthrough Cancer Therapy Developed By Israeli MedTech Startup Heads For Clinical Trials
Alpha Tau Medical's Alpha DaRT technology delivers high-precision alpha radiation that decays inside tumor, killing cancer cells while sparing surrounding healthy tissue.
November 07, 2018
Israeli MedTech Startup Alpha Tau Medical Raises $29M For Cancer Therapy
The medical company, founded in 2016, has developed an innovative alpha radiation cancer therapy that it says can kill cancer cells.
September 05, 2018
New Breakthrough In Adoptive Cell Transfer Therapy For Cancer
One of the latest attempts to boost the body’s defenses against cancer is called adoptive cell transfer. But this therapy is extremely expensive and not always technically feasible. Israeli scientists have now tested in mice a new form of the therapy, which overcomes the limitations and enhances the tumor-fighting ability of the cells.
August 01, 2011